Shouldn’t VIVUS Raise Capital Now? (VVUS)

February 23, 2012 · Filed Under Diabetes, fda, Financial, Heart, obesity, Secondary Offering 

While we have started mostly using The Wire at for our biotech and active trader posts (among many other aspects 50 to 100 times per day), we have a question for BioHealthInvestor readers after VIVUS, Inc. (NASDAQ: VVUS) has basically doubled on news of Qnexa getting a recommendation for approval from a FDA panel…

If you were the CEO or CFO of VIVUS, wouldn’t you immediately go out and raise capital now?

Our take is not just “yes” but a resounding yes.  With $150 million or so in net tangible assets as of September 30, 2011, with a ten-year history, and for many more reasons, this would seem like a shoe-in for a capital raise.


Set your RSS Readers and bookmarks to our Live Wire for continuous financial coverage.


10 Responses to “Shouldn’t VIVUS Raise Capital Now? (VVUS)”

  1. Neilesh on March 5th, 2012 12:01 am

    I came across your blog when googling for cool biotechnology articles – didn’t expect to find this, but enjoyed some of your posts. Keep it up.

  2. Technical Indicator on April 11th, 2012 12:20 pm

    Great work on the Biotech stock analysis Dr Melvin.

    I have enjoyed reading some of your posts and will come back for some more biotech insight soon.


  3. ft8rwfElite on September 10th, 2012 8:34 pm

    Automated High-Quality Multi-Level Link Building !

  4. Superman Leather Jacket on November 28th, 2013 3:34 pm

    Superb write-up I like the write-up enjoy how we outlined as much as possible, what you are doing a fantastic task most of other people just like you through of which sort of informative blogs supply attention to help people related to lots of things. We study another fascinating weblogs out of your internet sites and I will be a lot serious together with your blogging and site-building knowledge, I additionally started to produce blogs and this form weblogs really guide me personally out there. We currently book marked your current page and distributed your web sites for you to my own fellow workers not only everyone yet every one of them just like the blogging and site-building knowledge, trust anyone write additional exciting websites such as this one particular along with enjoy for the foreseeable future blogs.

  5. Superman Leather Jacket on November 28th, 2013 3:35 pm

    Exceptional article I really like your current content love the way you outlined all things, you do an incredible employment many of other folks as if you through that will style of educational blogs offer attention to be able to us associated with many points. We study some other intriguing information sites through your web sites as well as We are a lot engaged along with your blogs expertise, My spouse and i additionally started to compose information sites this also sort information sites actually help myself out. I witout a doubt saved the webpage as well as discussed the sites in order to my own friends not just everyone yet them all just like the blogging abilities, trust an individual create a lot more fascinating websites this way one and all the best . on your upcoming sites.

  6. zengda on April 5th, 2016 10:54 pm


  7. 544212911 on June 1st, 2016 9:59 pm


  8. 958034377 on June 16th, 2016 8:35 pm


  9. 增达信购 on June 28th, 2016 2:59 am


  10. Stock Trading on July 1st, 2016 7:08 am

    For Stock Trading download Meta Trader 4, which works perfectly in Windows, iOS and Android. MetaTrader 4 is the most popular trading platforms and user-friendly software for day trading.

Leave a Reply

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed